Skip to main content

AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

3.090 -0.220 (-6.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 23, 2024 Add to My Watchlist

Other Filings

Form 10QSB
Source: SEC/Edgar
August 14, 2005
Form PRE 14A
Source: SEC/Edgar
August 09, 2005
Form 10QSB/A
Source: SEC/Edgar
July 14, 2005
Form 10QSB
Source: SEC/Edgar
May 15, 2005
Form 10KSB
Source: SEC/Edgar
April 05, 2005
Form NT 10-K
Source: SEC/Edgar
March 30, 2005
Form 8-K
Source: SEC/Edgar
March 27, 2005
Form 8-K
Source: SEC/Edgar
February 01, 2005
Form NT 10-Q
Source: SEC/Edgar
November 15, 2004
Form 10QSB
Source: SEC/Edgar
November 15, 2004
Form 10QSB
Source: SEC/Edgar
August 15, 2004
Form 10QSB
Source: SEC/Edgar
May 16, 2004
Form 10KSB
Source: SEC/Edgar
March 21, 2004
Form 10QSB
Source: SEC/Edgar
November 06, 2003
Form 10QSB
Source: SEC/Edgar
August 12, 2003
Form 10QSB
Source: SEC/Edgar
May 13, 2003
Form 10KSB
Source: SEC/Edgar
April 08, 2003
Form NT 10-K
Source: SEC/Edgar
March 30, 2003
Form 10QSB
Source: SEC/Edgar
November 12, 2002
Form 10QSB/A
Source: SEC/Edgar
August 28, 2002
Form 10QSB
Source: SEC/Edgar
August 13, 2002
Form RW
Source: SEC/Edgar
July 29, 2002
Form 10QSB
Source: SEC/Edgar
May 19, 2002
Form NT 10-Q
Source: SEC/Edgar
May 13, 2002
Form 10KSB
Source: SEC/Edgar
April 11, 2002
Form NT 10-K
Source: SEC/Edgar
April 01, 2002
Form S-8
Source: SEC/Edgar
November 29, 2001
Form SB-2/A
Source: SEC/Edgar
November 27, 2001
Form 10QSB/A
Source: SEC/Edgar
November 26, 2001
Form 10KSB/A
Source: SEC/Edgar
November 26, 2001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.